Extended dosing of darbepoetin alfa in peritoneal dialysis patients. - Wikidata - awgldk - TriplyDB

Extended dosing of darbepoetin alfa in peritoneal dialysis patients.

Extended dosing of darbepoetin alfa in peritoneal dialysis patients.

http://www.wikidata.org/entity/Q33854988

about

Stable hemoglobin in hemodialysis patients: forest for the trees--a 12-week pilot observational study Differentiating factors between erythropoiesis-stimulating agents: an update to selection for anaemia of chronic kidney disease.

P2860

Q34493460-FE873C9B-29CB-48F6-A0BB-ABB02E129F2A Q38075798-A9C6338E-C795-4D02-810F-A1959C47092D

P2860

Extended dosing of darbepoetin alfa in peritoneal dialysis patients.

http://www.wikidata.org/entity/Q33854988

description

2011 nî lūn-bûn

@nan

2011 թուականի Մարտին հրատարակուած գիտական յօդուած

@hyw

2011 թվականի մարտին հրատարակված գիտական հոդված

@hy

2011年の論文

@ja

2011年論文

@yue

2011年論文

@zh-hant

2011年論文

@zh-hk

2011年論文

@zh-mo

2011年論文

@zh-tw

2011年论文

@wuu

name

Extended dosing of darbepoetin alfa in peritoneal dialysis patients.

@ast

Extended dosing of darbepoetin alfa in peritoneal dialysis patients.

@en

type

label

Extended dosing of darbepoetin alfa in peritoneal dialysis patients.

@ast

Extended dosing of darbepoetin alfa in peritoneal dialysis patients.

@en

prefLabel

Extended dosing of darbepoetin alfa in peritoneal dialysis patients.

@ast

Extended dosing of darbepoetin alfa in peritoneal dialysis patients.

@en

P1433

Q33854988-3E8846BB-E5CB-46FD-B51C-A09059753ED7

P1476

Q33854988-9FBA78E2-CCD7-4FEC-91C4-F873D5D1F7F9

P2093

Q33854988-01B87871-E3FD-4C77-91FF-8585F8C41C2C

Q33854988-21D0C820-562F-4D9A-83EC-451594DCEADF

Q33854988-28612A7F-4E1F-43F4-9703-B3D07F4A3348

Q33854988-2CAC1609-8AC9-4F30-9C13-3F42DDB27496

Q33854988-CF0A7E6C-BFC9-4090-834D-D801DC96BF1E

Q33854988-D031B577-658C-4149-AD88-1CCCFE925C6D

Q33854988-E15B3219-0F5A-4548-B684-1E31486ABCFD

P2860

Q33854988-22FD11D6-F071-4350-8013-E07D097F932F

Q33854988-27301138-6BC5-4094-B80A-6EAC89AC5AAA

Q33854988-2E07B1ED-EB0B-476D-B9BB-0225BD03B3B6

Q33854988-5740930B-E2AC-449E-8008-58C1D64E66CD

Q33854988-5C1D26B4-AFBD-41DE-B2D1-CA02ADAC0AFE

Q33854988-930D7F83-35F4-45F6-A440-0F31F2E193AC

Q33854988-947CE6FD-6482-443D-B493-2D633D382598

Q33854988-C76E510D-11EB-41AD-99B8-8F6B0D7549AF

Q33854988-C7B33CCE-E1F5-4798-97DD-8670E4B20ABC

Q33854988-D593DA4D-7041-4C0B-AFEC-1ED6321F477D

P2888

Q33854988-D5EE1594-CE43-4009-9B90-868DDE63F7E9

P304

Q33854988-9CC46C0D-F9BD-4257-A1C9-8E23DDB26BDD

P31

Q33854988-4830C337-0FEC-427F-BF80-B7BD436E8F18

P356

Q33854988-0D6EC663-7EEC-48CE-BBD5-AFCF98D115BD

P478

Q33854988-F2D28C55-41C7-4222-BCB6-EF5103B86AC7

P577

Q33854988-17E7AAF9-F0DB-4BEB-88A9-4C41FC64A942

P5875

Q33854988-867073B2-0255-4274-9435-2999FC9869F9

P6179

Q33854988-16365BB1-ECCE-4B91-917F-56771B8C35C7

P698

Q33854988-04814DFB-EC19-468A-BC4C-3B6C21E0A848

P921

Q33854988-16B4E6D4-4806-424E-A311-D076695EFF00

Q33854988-52490F88-7D98-47ED-A456-07963F250F37

P932

Q33854988-3758329B-27AA-4AE4-A031-3C1EE5FAD3B9

P356

1471-2369-12-13

P1433

P1476

Extended dosing of darbepoetin alfa in peritoneal dialysis patients.

@en

P2093

Ian Bridges

http://www.w3.org/2001/XMLSchema#string

Jacques B Rottembourg

http://www.w3.org/2001/XMLSchema#string

Johan M J De Meester

http://www.w3.org/2001/XMLSchema#string

Lawrence P McMahon

http://www.w3.org/2001/XMLSchema#string

Mariano Feriani

http://www.w3.org/2001/XMLSchema#string

Mourad Farouk

http://www.w3.org/2001/XMLSchema#string

Wolfgang Pronai

http://www.w3.org/2001/XMLSchema#string

P2860

Novel erythropoiesis stimulating protein

Erythropoietin and anemia.

The impact of reducing dose frequency on health outcomes.

Revised European best practice guidelines for the management of anaemia in patients with chronic renal failure.

The impact of guidelines for the prevention of anemia on clinical outcome.

How to optimise anaemia therapy in peritoneal dialysis patients.

Peritoneal dialysis utilization and outcome: what are we facing?

Extended administration of erythropoiesis-stimulating agents for optimising the management of renal anaemia: what is the evidence?

Hemodialysis and peritoneal dialysis: comparison of adjusted mortality rates according to the duration of dialysis: analysis of The Netherlands Cooperative Study on the Adequacy of Dialysis 2.

Epidemiology of anemia associated with chronic renal insufficiency among adults in the United States: results from the Third National Health and Nutrition Examination Survey.

P2888

1471-2369-12-13

P304

13

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1186/1471-2369-12-13

http://www.w3.org/2001/XMLSchema#string

P478

12

http://www.w3.org/2001/XMLSchema#string

P577

2011-03-24T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

50849723

http://www.w3.org/2001/XMLSchema#string

P6179

1031709493

http://www.w3.org/2001/XMLSchema#string

P698

21435267

http://www.w3.org/2001/XMLSchema#string

P921

Darbepoetin alfa

P932

3072319

http://www.w3.org/2001/XMLSchema#string